By Sunovion Pharmaceuticals Inc. This app is intended only for US health care professionals involved in the treatment of patients with bipolar disorder and is for educational purposes only. It is provided by Sunovion Pharmaceuticals Inc. and was developed in collaboration with expert faculty who are consultants for Sunovion. The information contained in the app is intended for general informational purposes only and is not a substitute for your professional medical advice and judgment. The multidisciplinary faculty consists of 6 psychiatrists, 3 primary care physicians, and 4 psychiatric nurse practitioners who walk you through 10 hypothetical patient case studies (adult and pediatric) depicting approaches to common diagnostic and management challenges in bipolar depression. The app also puts a variety of helpful tools and resources at your fingertips, including 5 validated screening tools, a review of relevant DSM-5 information, and an overview of a potential treatment option. Download this educational clinical companion today. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd. ©2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 LAT1170-17 less
|
